Ingrowing nail

L12_NAIL_INGROW

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L60.0 Hospital discharge: ICD-9 — 7030A Hospital discharge: ICD-8 — 70302 Cause of death: ICD-10 — L60.0 Cause of death: ICD-9 — 7030A Cause of death: ICD-8 — 70302 2 out of 7 registries used, show all original rules.	2225
4. Check minimum number of events None	2225
5. Include endpoints None	2225
6. Filter based on genotype QC (FinnGen only)	2140

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60
Name in latin: Unguis incarnatus

NAME	L12_NAIL_INGROW
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L600
HD_ICD_9	7030A
HD_ICD_8	70302
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L600
COD_ICD_9	7030A
COD_ICD_8	70302
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Ingrowing nail based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17737	7233	10429
Only index persons	16406	6643	9763
Unadjusted period prevalence (%)
Whole population	0.26	0.21	0.29
Only index persons	0.32	0.24	0.37
Median age at first event (years)
Whole population	31.79	48.16	20.32
Only index persons	30.95	46.59	20.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2140	1135	1005
Unadjusted period prevalence (%)	0.43	0.40	0.46
Median age at first event (years)	41.67	49.32	33.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2225: Matched controls
22250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L60.0

ICD-10 Finland

Ingrowing nail

344.3

307.7

1938

428

L03.0

ICD-10 Finland

Cellulitis of finger and toe

8.1

307.7

603

979

QDH01

NOMESCO Finland

Excision of nail bed in toe

1142.7

307.7

380

QDH00

NOMESCO Finland

Avulsion of toe nail

242.0

307.7

257

QDH05

NOMESCO Finland

Correction of deformity of toe nail

104.1

283.0

146

7030A

ICD-9 Finland

Diseases of nail, Ingrowing nail

+∞

219.5

207

S94

ICPC

Ingrowing nail

12.9

162.6

161

134

J01FF01

ATC

clindamycin; systemic

3.0

129.4

840

3720

70302

ICD-8 Finland

Diseases of nail, Unguis incarnatus

+∞

107.2

102

S22

ICPC

Nail symptom/complaint

4.5

103.7

273

664

S09

ICPC

Infected finger/toe

6.1

93.5

171

302

J01DB01

ATC

cefalexin; oral

3.8

85.9

2007

15698

RJ410, ,

NOMESCO Finland

30.7

82.1

RJ411, ,

NOMESCO Finland

18.2

76.8

RJ421, ,

NOMESCO Finland

26.6

75.3

RJ425, ,

NOMESCO Finland

183.2

68.5

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.3

67.1

116

193

J01DA01

ATC

[U] cefalexin

2.2

67.1

1472

10411

A10AB01

ATC

insulin (human); parenteral

4.7

65.7

159

359

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

4.1

63.6

186

486

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

62.5

631

3267

L17

ICPC

Foot/toe symptom/complaint

2.2

61.8

727

4004

A10AB04

ATC

insulin lispro; parenteral

4.9

61.5

142

308

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.2

61.1

169

423

RJ420, ,

NOMESCO Finland

17.6

61.1

A10AC01

ATC

insulin (human); parenteral

3.3

60.1

246

805

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

60.0

595

3049

D06AX01

ATC

fusidic acid; topical

2.9

58.5

303

1136

A10AB05

ATC

insulin aspart; parenteral

3.2

58.0

246

822

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

57.6

270

957

L84

ICD-10 Finland

Corns and callosities

4.8

56.7

131

284

J01CF05

ATC

flucloxacillin; systemic

3.5

56.6

211

650

C03CA01

ATC

furosemide; systemic

2.2

56.1

583

3036

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

55.7

151

372

A10AE04

ATC

insulin glargine; parenteral

2.9

53.4

275

1025

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

10.1

52.6

N02AX02

ATC

tramadol; systemic, rectal

2.0

51.9

972

6266

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.2

50.5

144

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.5

48.7

124

291

H04AA01

ATC

glucagon; nasal, parenteral

4.8

48.7

112

242

A11CC03

ATC

alfacalcidol; systemic

5.8

48.6

160

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.1

47.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

47.4

312

1317

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.6

47.3

114

256

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

9.0

45.9

A10AA01, ,

ATC

4.5

44.2

110

253

A10AA02, ,

ATC

4.2

43.0

118

293

T89

ICPC

Diabetes insulin dependent

3.5

42.4

151

450

L04AA06

ATC

mycophenolic acid; systemic

5.7

42.3

145

A10AE05

ATC

insulin detemir; parenteral

3.2

42.0

176

581

N03AX16

ATC

[U] pregabalin

2.1

41.9

532

2950

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.5

40.6

147

L60.9

ICD-10 Finland

Nail disorder, unspecified

6.6

40.6

103

R4180

NOMESCO Finland

Podiatric therapy

7.4

40.3

L60.8

ICD-10 Finland

Other nail disorders

7.7

40.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

39.6

297

1327

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

39.1

624

3735

TQW80

NOMESCO Finland

Local dermatologic skincare

4.9

39.0

183

127

Kela drug reimbursment

Transplant complication

5.9

38.9

121

H3603, E103,

ICD-10 Finland

7.4

38.6

H02AB04

ATC

methylprednisolone; systemic

2.3

38.6

340

1629

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

38.5

835

5505

J01MA02

ATC

ciprofloxacin; systemic

1.8

38.4

819

5372

NHQ40

NOMESCO Finland

Amputation of toe

7.5

38.2

SPAT1262

SPAT

Handing over of treatment supplies

2.2

38.2

396

2026

L04AA01

ATC

[U] ciclosporin

7.2

38.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

38.1

476

2613

SPAT1143

SPAT

Partial or complete excision of nail

9.2

37.8

A46

ICD-10 Finland

Erysipelas

2.3

37.4

327

1560

E0000UV, ,

ATC

1.8

36.8

938

6465

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.0

36.7

174

616

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

10.7

36.7

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

13.8

36.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

35.9

265

1174

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.3

35.6

139

RJ426, ,

NOMESCO Finland

+∞

35.5

RJ190, ,

NOMESCO Finland

53.5

35.5

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.5

35.4

Z94.0

ICD-10 Finland

Kidney transplant status

6.9

35.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

34.0

131

410

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

33.8

932

6526

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.3

33.3

208

R60.0

ICD-10 Finland

Localized oedema

2.3

33.2

263

1201

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

32.9

645

4084

N18.8

ICD-10 Finland

Other chronic renal failure

5.1

32.8

138

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

32.5

138

458

A12AA04

ATC

calcium carbonate; oral

6.1

32.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

32.5

147

507

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

32.4

465

2664

ZXA05

NOMESCO Finland

Left side

1.9

32.4

515

3052

S18

ICPC

Laceration/cut

1.7

32.2

945

6703

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

32.1

213

897

L60.1

ICD-10 Finland

Onycholysis

7.1

31.8

J01DA09

ATC

[U] cefadroxil

1.8

31.6

595

3714

A02BC02

ATC

pantoprazole; systemic

1.7

31.6

1408

11148

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

31.6

219

941

TQW99

NOMESCO Finland

Other minor procedure on skin

3.3

31.6

124

393

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.6

31.2

164

L73.8

ICD-10 Finland

Other specified follicular disorders

12.1

30.8

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.3

30.6

N02BE01

ATC

paracetamol; systemic, rectal

2.1

30.5

1916

16700

E66.8

ICD-10 Finland

Other obesity

2.8

30.4

155

571

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.2

30.2

A10BA02

ATC

metformin; oral

1.8

29.9

553

3425

M79.6

ICD-10 Finland

Pain in limb

1.7

29.0

897

6403

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.3

29.0

111

M25.5

ICD-10 Finland

Pain in joint

1.7

28.7

714

4804

H02AB06

ATC

prednisolone; systemic

1.7

28.6

981

7181

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.4

28.3

200

865

J01MA12

ATC

levofloxacin; systemic

2.0

28.3

383

2142

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.4

28.3

106

L04AD01

ATC

ciclosporin; systemic

4.7

28.1

145

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

27.9

400

2279

J02AC01

ATC

fluconazole; systemic

1.7

27.9

792

5515

N02AA05

ATC

oxycodone; systemic

2.0

27.8

337

1812

H3601, E103,

ICD-10 Finland

6.5

27.8

9759

FHL

Other measure in this category

146.9

27.7

Z3231

NOMESCO Finland

Registered nurse

1.8

27.6

589

3792

205

Kela drug reimbursment

Chronic hypertension

1.8

27.5

458

2737

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

27.5

950

6946

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

27.1

286

1461

S97

ICPC

Chronic ulcer skin

2.8

26.9

136

498

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

10.9

26.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.2

26.9

256

1257

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.3

26.7

UJF32

NOMESCO Finland

Coloscopy

1.8

26.7

510

3174

RJ511, ,

NOMESCO Finland

46.3

26.5

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.4

26.3

D01BA02

ATC

terbinafine; oral

1.8

26.1

539

3430

TK800

NOMESCO Finland

Hemodialysis

4.4

26.0

150

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

26.0

229

1089

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

25.7

299

1582

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

25.6

492

3065

V03AE02

ATC

sevelamer; oral

10.5

25.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

25.3

264

1342

V03AE01

ATC

polystyrene sulfonate; oral

6.4

25.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

25.1

439

2656

D01AE16

ATC

amorolfine; topical

2.1

25.0

250

1250

N03AX12

ATC

[U] gabapentin; oral

1.9

24.7

349

1973

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.8

24.6

A10AD01

ATC

insulin (human); parenteral

4.5

24.6

136

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

24.5

103

340

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

24.5

142

559

SPAT1229

SPAT

Assessment of need for aid

2.5

24.2

159

665

D07AC01

ATC

betamethasone; topical

1.6

23.9

731

5140

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

8.1

23.9

B35.1

ICD-10 Finland

Tinea unguium

2.5

23.6

159

672

9751

FHL

Nail removal in the operating room or under anesthesia

126.4

23.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

23.5

277

1470

T90

ICPC

Diabetes non-insulin dependent

1.8

23.5

442

2729

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

23.4

1148

9003

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

23.4

149

614

B01AB05

ATC

enoxaparin; parenteral

1.7

23.3

600

4036

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

23.3

906

6739

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.0

23.3

102

D07AB08

ATC

desonide; topical

2.1

23.1

243

1238

ZXA00

NOMESCO Finland

Right side

1.7

23.0

518

3360

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

22.7

458

2882

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

22.6

541

3564

L70.0

ICD-10 Finland

Acne vulgaris

4.0

22.6

163

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

22.5

462

2920

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

22.4

151

639

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.5

22.3

230

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

22.2

754

5417

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

22.1

1079

8411

Z71.8

ICD-10 Finland

Other specified counselling

1.6

22.0

670

4687

A06AD11

ATC

lactulose; oral

2.0

22.0

271

1460

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

21.9

295

1638

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.9

21.9

103

363

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.8

21.8

176

M04AA01

ATC

allopurinol; systemic

2.1

21.7

229

1167

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.7

21.7

J01XC01

ATC

fusidic acid; systemic

4.9

21.6

L04AX01

ATC

azathioprine; systemic

2.8

21.5

111

411

J01FA10

ATC

azithromycin; systemic

1.5

21.5

1286

10461

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

21.4

495

3225

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

21.2

198

962

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.0

21.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.5

21.2

144

611

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

20.9

498

3268

M03BX02

ATC

tizanidine; oral

1.5

20.9

1315

10782

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

20.8

615

4262

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

20.8

395

2437

C07AB07

ATC

bisoprolol; oral

1.5

20.7

857

6414

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.2

20.7

R06.0

ICD-10 Finland

Dyspnoea

1.7

20.6

511

3388

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.4

20.4

J01AA02

ATC

doxycycline; systemic

1.6

20.4

1565

13366

Z49.2

ICD-10 Finland

Other dialysis

6.7

20.4

ZXA10

NOMESCO Finland

Bilateral

1.8

20.4

364

2205

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.3

20.3

R06AE07

ATC

cetirizine; oral

1.5

20.3

943

7228

WX002

NOMESCO Finland

Sedation and analgesia

1.8

20.3

382

2350

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

20.2

229

1197

J01FA06

ATC

roxithromycin; oral

1.5

20.1

793

5863

E000001, ,

ATC

1.7

20.1

430

2740

G47.3

ICD-10 Finland

Sleep apnoea

1.7

20.1

477

3125

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.4

19.9

116

QCH00

NOMESCO Finland

Avulsion of finger nail

58.1

19.9

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

19.9

427

2722

C08CA01

ATC

amlodipine; oral

1.6

19.8

673

4807

A10BJ06

ATC

semaglutide; parenteral

2.5

19.8

124

507

R01AD08

ATC

fluticasone; nasal

1.6

19.6

610

4269

B35.3

ICD-10 Finland

Tinea pedis

2.6

19.6

112

438

D07AC13

ATC

mometasone; topical

1.6

19.5

588

4082

N05BA04

ATC

oxazepam; oral

1.6

19.4

521

3516

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

19.4

626

4415

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.0

19.4

136

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

19.3

242

1309

137

Kela drug reimbursment

Uraemia requiring dialysis

5.8

19.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

19.2

434

2802

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

19.2

322

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

19.2

645

4591

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

19.2

133

570

L60

ICD-10 Finland

Nail disorders

7.0

19.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

19.0

694

5029

M54.5

ICD-10 Finland

Low back pain

1.5

19.0

756

5585

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

18.9

213

1111

R51.80

ICD-10 Finland

Headache

1.8

18.8

349

2134

B05DB

ATC

Hypertonic solutions

6.6

18.8

ZX120

NOMESCO Finland

Intravenous

2.1

18.8

196

994

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.7

18.7

158

RJ414, ,

NOMESCO Finland

23.9

18.6

M01AE02

ATC

naproxen; oral, rectal

1.5

18.6

1207

9850

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

18.6

456

3006

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

4.6

18.5

Z3226

NOMESCO Finland

Physiotherapist

1.7

18.4

373

2338

R03AC02

ATC

salbutamol; inhalant

1.5

18.3

1149

9302

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.0

18.2

277

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

18.1

136

604

H36.01

ICD-10 Finland

Diabetic maculopathy

4.4

18.1

104

SPAT1263

SPAT

Sampling

1.5

18.0

859

6576

J01CF02

ATC

cloxacillin; systemic

3.7

17.9

153

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

17.9

595

4212

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

17.9

373

2353

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

7.3

17.8

L04AD02

ATC

tacrolimus; systemic

4.8

17.8

R50.9

ICD-10 Finland

Fever, unspecified

1.8

17.6

324

1973

S76

ICPC

Skin infection other

2.5

17.6

115

479

N30.0

ICD-10 Finland

Acute cystitis

1.8

17.6

308

1850

P01AB01

ATC

metronidazole; oral, rectal

1.5

17.5

774

5821

WZC30

NOMESCO Finland

Teaching

1.8

17.5

309

1861

A02BC05

ATC

esomeprazole; systemic

1.5

17.5

786

5934

L04AX03

ATC

methotrexate; systemic

2.0

17.5

208

1105

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

17.4

156

745

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

17.4

195

1014

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

17.3

275

1604

S29

ICPC

Skin symptom/complaint other

1.7

17.3

374

2381

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.4

17.3

186

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

17.3

148

695

R11

ICD-10 Finland

Nausea and vomiting

2.0

17.2

189

976

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

17.1

200

1055

ZXD05

NOMESCO Finland

Urgent procedure

1.5

17.1

598

4274

XQ800

NOMESCO Finland

Prick test

2.1

17.1

167

825

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

17.0

378

2423

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

17.0

A02BC01

ATC

omeprazole; systemic

1.6

16.9

496

3407

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

16.9

780

5911

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.4

16.7

185

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

16.7

195

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

16.6

532

3725

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

16.6

289

1731

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

16.6

293

1762

D07AD01

ATC

clobetasol; topical

1.7

16.5

320

1976

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.5

517

3604

L60.3

ICD-10 Finland

Nail dystrophy

14.4

16.3

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

16.3

288

1734

R07.3

ICD-10 Finland

Other chest pain

1.9

16.2

217

1198

C10AA05

ATC

atorvastatin; oral

1.5

16.2

717

5376

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

16.2

174

891

B07.9

ICD-10 Finland

Verruca simplex

2.6

16.1

354

L85.89

ICD-10 Finland

Other specified epidermal thickening

24.7

16.0

N06AX11

ATC

mirtazapine; oral

1.5

16.0

677

5030

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

15.9

218

1213

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

15.9

237

1355

B05DA

ATC

Isotonic solutions

5.7

15.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

15.9

327

2053

SPAT1301

SPAT

No procedures

1.5

15.8

599

4346

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

15.8

1527

13271

RJ521, ,

NOMESCO Finland

60.5

15.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

15.7

1114

9128

160

Kela drug reimbursment

exenatide

3.4

15.6

163

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

15.6

196

1059

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

15.6

871

6820

SPAT1310

SPAT

Counselling related to known health issue

1.5

15.6

632

4647

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

15.6

531

3764

J01EA01

ATC

trimethoprim; systemic

1.6

15.6

463

3183

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

15.4

1557

13607

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

15.4

226

1285

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

15.4

734

5573

A10BJ02

ATC

liraglutide; parenteral

2.9

15.4

248

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.2

15.3

C09AA02

ATC

enalapril; systemic

1.7

15.3

320

2016

CKC12

NOMESCO Finland

Photocoagulation of retina

2.6

15.2

370

L01BA01

ATC

methotrexate; systemic

2.8

15.2

289

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

15.2

269

1619

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

15.2

202

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

15.1

198

1085

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.2

15.1

R42

ICD-10 Finland

Dizziness and giddiness

1.6

15.1

408

2741

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

15.1

167

N02BF02

ATC

pregabalin; oral

2.2

15.1

130

612

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

14.8

294

1824

A10BH01

ATC

sitagliptin; oral

2.0

14.8

173

912

R4110

NOMESCO Finland

Physiotherapy

1.5

14.8

533

3816

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.8

14.8

259

RJ210, ,

NOMESCO Finland

16.6

14.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

14.7

671

5043

SPAT1153

SPAT

Removal of sutures

1.5

14.6

569

4139

B01AC04

ATC

clopidogrel; oral

1.8

14.6

259

1557

SFA20

NOMESCO Finland

Two-surface restoration

1.4

14.6

1240

10437

N06AX21

ATC

duloxetine; oral

1.8

14.6

240

1412

A07AA09

ATC

vancomycin; oral

4.2

14.6

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

14.6

223

A10AE06

ATC

insulin degludec; parenteral

2.5

14.6

366

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

14.6

307

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

14.5

262

1583

D07AA02

ATC

hydrocortisone; topical

1.7

14.5

300

1884

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.0

14.4

105

L72.1

ICD-10 Finland

Trichilemmal cyst

2.4

14.4

104

454

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

14.4

130

623

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

14.4

981

7935

N06AA09

ATC

amitriptyline; systemic

1.9

14.4

177

951

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

14.3

218

1254

L30.4

ICD-10 Finland

Erythema intertrigo

4.1

14.3

R52.9

ICD-10 Finland

Pain, unspecified

1.9

14.2

198

1107

R4120

NOMESCO Finland

Occupational therapy

2.1

14.2

141

702

Z01.2

ICD-10 Finland

Dental examination

1.4

14.1

953

7685

N06AX16

ATC

venlafaxine; oral

1.7

14.1

305

1936

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

14.1

127

609

SPAT1312

SPAT

General health counselling

1.5

14.0

637

4775

AA1AD

NOMESCO Finland

CT of head and brain

1.5

14.0

469

3303

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.3

14.0

155

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.1

14.0

133

651

G44.2

ICD-10 Finland

Tension-type headache

1.7

14.0

282

1758

D01AE15

ATC

terbinafine; topical

2.1

13.9

141

706

XQ848

NOMESCO Finland

Dermatological photography

3.0

13.9

202

J01DA06

ATC

[U] cefuroxime

1.7

13.9

280

1745

RJ422, ,

NOMESCO Finland

53.7

13.8

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

13.8

393

2669

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.3

13.7

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.3

13.7

152

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.5

13.7

371

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

13.6

190

1063

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

13.6

313

2018

J01FA09

ATC

clarithromycin; systemic

1.5

13.6

630

4736

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

13.6

177

969

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

13.5

1136

9490

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

5.5

13.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

13.5

114

532

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

13.5

214

1245

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

13.4

282

1775

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

13.4

106

WX892

NOMESCO Finland

Monitored bed care

2.0

13.4

147

758

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

13.4

228

1355

C10AA01

ATC

simvastatin; oral

1.5

13.4

648

4909

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

13.3

193

1092

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

13.3

181

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.5

13.2

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.4

13.2

383

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

13.2

115

544

A28

ICPC

Limited function/disability NOS

1.7

13.2

263

1633

K02.1

ICD-10 Finland

Caries of dentine

1.4

13.1

1275

10893

T82

ICPC

Obesity

2.4

13.1

391

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

13.1

448

3164

ZXC10

NOMESCO Finland

Use of laser

3.1

13.1

172

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

13.1

347

2315

A10BB12

ATC

glimepiride; oral

2.2

13.1

108

500

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.7

13.0

113

L28

ICPC

Limited function/disability (L)

1.6

13.0

290

1854

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

13.0

443

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

13.0

259

1608

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

16.8

13.0

N02BF01

ATC

gabapentin; oral

1.9

13.0

165

896

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

12.9

135

684

R01AD09

ATC

mometasone; nasal

1.4

12.9

929

7538

J01CE08

ATC

benzathine benzylpenicillin; parenteral

5.0

12.9

SPAT1260

SPAT

Consultation of another employee

1.6

12.9

331

2191

E000006, ,

ATC

2.0

12.8

134

680

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.2

12.8

164

A01

ICPC

Pain general/multiple sites

1.8

12.8

183

1032

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

12.8

408

B03XA01

ATC

erythropoietin; parenteral

5.4

12.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

12.7

112

532

ACC51

NOMESCO Finland

Release of median nerve

2.0

12.7

148

780

C08CA13

ATC

lercanidipine; oral

1.7

12.7

241

1476

A10BJ05

ATC

dulaglutide; parenteral

3.1

12.7

170

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

12.7

341

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.7

12.7

241

H02AB07

ATC

prednisone; oral

1.7

12.7

246

1516

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.1

12.6

128

642

R53

ICD-10 Finland

Malaise and fatigue

1.5

12.6

454

3238

L03

ICD-10 Finland

Cellulitis

4.7

12.6

N05CF01

ATC

zopiclone; oral

1.5

12.6

576

4309

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

12.6

117

568

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.5

759

5973

D02AE01

ATC

carbamide; topical

2.0

12.5

132

672

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

12.5

267

1688

A07AA02

ATC

nystatin; oral

2.2

12.4

106

497

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

12.4

124

618

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.6

12.4

290

SPAT1211

SPAT

Application of soft bandage

1.8

12.4

177

997

A10BJ01

ATC

exenatide; parenteral

4.5

12.4

A02BA02

ATC

ranitidine; systemic

1.6

12.3

325

2164

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

12.3

286

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

12.2

286

1849

M01AC06

ATC

meloxicam; systemic, rectal

1.4

12.2

663

5112

H3600, E103,

ICD-10 Finland

3.7

12.2

104

E000003, ,

ATC

2.3

12.2

429

C07AB02

ATC

metoprolol; systemic

1.6

12.2

312

2061

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.9

12.2

201

B03XA02

ATC

darbepoetin alfa; parenteral

3.3

12.2

143

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

12.2

147

784

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

12.2

267

1698

R03BA05

ATC

fluticasone; inhalant

1.6

12.2

357

2434

M02AA07

ATC

piroxicam; topical

1.4

12.2

625

4772

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

12.1

214

1285

XCK00

NOMESCO Finland

Perimetry

2.1

12.1

109

523

ZXE00

NOMESCO Finland

One hour or less

1.4

12.1

734

5772

C08CA02

ATC

felodipine; oral

1.9

12.0

149

802

B37.2

ICD-10 Finland

Candidiasis of skin and nail

5.0

11.9

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

13.4

11.9

RJ412, ,

NOMESCO Finland

13.4

11.9

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.9

11.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

11.9

119

594

N18.0

ICD-10 Finland

End-stage renal disease

4.6

11.9

C02AC05

ATC

moxonidine; oral

2.4

11.8

365

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

11.8

213

1286

L57.0

ICD-10 Finland

Actinic keratosis

1.9

11.8

155

851

S80.0

ICD-10 Finland

Contusion of knee

1.9

11.7

159

882

M48.0

ICD-10 Finland

Spinal stenosis

1.7

11.7

201

1198

L03.3

ICD-10 Finland

Cellulitis of trunk

4.8

11.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

11.6

443

3192

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

11.6

150

819

SPAT1216

SPAT

Assessment of functional ability

1.6

11.6

254

1615

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

11.6

123

628

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

11.6

647

5007

Z00.0

ICD-10 Finland

General medical examination

1.5

11.5

376

2625

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

11.5

310

2074

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

13.7

11.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.4

549

4133

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.1

11.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

11.4

198

A02BC03

ATC

lansoprazole; oral

1.5

11.4

500

3703

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

11.3

159

891

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

11.3

101

483

L04AB01

ATC

etanercept; parenteral

3.3

11.2

130

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.3

11.2

125

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

11.2

411

2936

R4190

NOMESCO Finland

Nutritional therapy

2.3

11.2

393

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

11.2

189

1120

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.8

11.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

11.1

116

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

11.1

359

2498

M77.4

ICD-10 Finland

Metatarsalgia

2.0

11.1

122

631

A08

ICPC

Swelling

2.2

11.0

441

RD210, ,

NOMESCO Finland

3.0

11.0

163

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

11.0

396

C03AA03

ATC

hydrochlorothiazide; oral

1.9

11.0

145

797

N05BA01

ATC

diazepam; systemic, rectal

1.6

11.0

247

1580

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

10.9

343

2373

N05AH04

ATC

quetiapine; oral

1.5

10.9

368

2585

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

10.8

128

678

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

10.8

133

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

10.8

133

714

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.9

10.8

170

J05AB01

ATC

aciclovir; systemic

1.5

10.8

407

2921

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

10.8

522

3929

A10AD04

ATC

insulin lispro; parenteral

10.6

10.8

D07XC01

ATC

betamethasone; topical

1.7

10.8

216

1342

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

10.7

449

3289

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

10.7

102

500

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.9

10.7

171

QCH01

NOMESCO Finland

Excision of nail bed in finger

28.2

10.7

WW200

NOMESCO Finland

Immunization

2.6

10.7

245

9733

FHL

Excision of skin change in operating room or anesthesia

3.7

10.7

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

10.7

239

1527

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

10.7

276

1826

C10AA07

ATC

rosuvastatin; oral

1.4

10.7

543

4123

K59.0

ICD-10 Finland

Constipation

2.1

10.7

102

501

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.9

10.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.6

239

1528

Z96.4

ICD-10 Finland

Presence of endocrine implants

13.0

10.6

A10BK03

ATC

empagliflozin; oral

1.8

10.6

175

1030

M01AH05

ATC

etoricoxib; oral

1.3

10.6

1222

10565

L12

ICPC

Hand/finger symptom/complaint

1.5

10.6

325

2235

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

10.6

169

986

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

10.6

456

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

10.5

110

558

C03DA01

ATC

spironolactone; oral

1.7

10.5

189

1139

C10AX09

ATC

ezetimibe; oral

1.6

10.5

263

1726

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

10.5

417

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

10.5

103

511

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

10.5

345

2408

Z2221

NOMESCO Finland

Medical doctor

1.4

10.5

512

3859

SPAT1254

SPAT

Administration of medicine

1.6

10.4

275

1827

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

10.4

114

588

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

10.4

568

4362

QDH10

NOMESCO Finland

Transfer of toe nail, microsurgical

+∞

10.4

J20

ICD-10 Finland

Acute bronchitis

1.7

10.4

191

1158

H05BX01

ATC

cinacalcet; oral

5.4

10.4

J01CA04

ATC

amoxicillin; systemic

1.4

10.4

1741

15945

-1, ,

NOMESCO Finland

1.4

10.3

701

5584

J01MA14

ATC

moxifloxacin; systemic

1.8

10.3

161

933

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.9

10.3

WX290

NOMESCO Finland

Other blockage of nerve

1.3

10.3

1008

8494

A10BX04

ATC

[U] exenatide

4.0

10.2

N19

ICD-10 Finland

Unspecified kidney failure

2.6

10.2

233

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

10.2

154

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

10.2

362

2566

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

10.2

1430

12699

L85.3

ICD-10 Finland

Xerosis cutis

4.2

10.1

H3600, E113,

ICD-10 Finland

4.2

10.1

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.9

10.1

UKC02

NOMESCO Finland

Cystoscopy

1.6

10.1

236

1524

WX320

NOMESCO Finland

Spinalanesthesy

1.5

10.1

415

3027

M10

ICD-10 Finland

Gout

2.3

10.1

333

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.3

10.1

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.0

10.0

J01FA01

ATC

erythromycin; systemic

1.6

10.0

274

1835

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.5

10.0

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

10.0

508

3852

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

10.0

136

756

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

10.0

174

1041

E87.5

ICD-10 Finland

Hyperkalaemia

3.5

9.9

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.0

9.9

146

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.8

121

651

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

9.8

110

573

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

9.8

158

924

M10.9

ICD-10 Finland

Gout, unspecified

2.0

9.8

106

546

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

9.8

275

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

9.7

257

E000002, ,

ATC

1.6

9.7

218

1393

R01AD58

ATC

fluticasone, combinations; nasal

1.4

9.7

497

3772

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

9.7

1424

12682

E66

ICD-10 Finland

Obesity

2.0

9.7

110

576

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.2

9.6

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

9.6

124

677

C01DA14

ATC

isosorbide mononitrate; oral

1.7

9.6

199

1246

S06

ICPC

Rash localized

2.0

9.6

105

542

L16

ICPC

Ankle symptom/complaint

1.6

9.6

227

1470

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.3

9.6

107

D11

ICPC

Diarrhoea

1.6

9.6

243

1600

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

9.6

143

818

C07AG02

ATC

carvedilol; oral

2.0

9.5

488

M01AB01

ATC

indometacin; systemic, rectal

1.9

9.5

117

629

N06AA10

ATC

nortriptyline; systemic

2.7

9.5

183

R06.4

ICD-10 Finland

Hyperventilation

3.1

9.5

123

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

9.5

224

C09CA01

ATC

losartan; oral

1.4

9.5

415

3060

R06AX22

ATC

ebastine; oral

1.5

9.5

326

2294

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

9.5

137

776

R10.0

ICD-10 Finland

Acute abdomen

2.4

9.5

279

H26.4

ICD-10 Finland

After-cataract

1.8

9.5

141

806

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

9.4

134

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

9.4

122

667

I50.0

ICD-10 Finland

Congestive heart failure

2.0

9.4

504

R52.2

ICD-10 Finland

Other chronic pain

2.2

9.4

350

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.3

301

2089

QDH00, ,

SPAT

8.1

9.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

9.3

227

1481

R05

ICD-10 Finland

Cough

1.4

9.3

386

2819

SPAT1255

SPAT

Intravenous administration of medicine

1.9

9.2

116

628

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

7.3

9.2

R06AX27

ATC

desloratadine; oral

1.4

9.2

579

4542

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

9.2

246

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.5

9.2

240

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

9.1

126

703

C10AA03

ATC

pravastatin; oral

1.9

9.1

112

602

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.3

9.1

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

9.1

428

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

9.1

321

2270

A08AB01

ATC

orlistat; oral

4.4

9.1

L20.0

ICD-10 Finland

Besnier prurigo

1.7

9.1

160

960

M01CB01

ATC

sodium aurothiomalate; parenteral

3.8

9.1

A10AA03, ,

ATC

4.0

9.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.1

9.0

382

RJ512, ,

NOMESCO Finland

15.7

9.0

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.1

9.0

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

9.0

376

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

9.0

478

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.5

9.0

224

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

9.0

133

759

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

9.0

267

Z00.8

ICD-10 Finland

Other general examinations

1.7

9.0

153

910

R03BA02

ATC

budesonide; inhalant

1.5

9.0

334

2387

XA402

NOMESCO Finland

ENMG

2.6

8.9

195

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

8.9

237

NHG82

NOMESCO Finland

Fusion of other tarsal joint

3.9

8.9

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

8.8

193

1225

H01

ICPC

Ear pain/earache

1.6

8.8

233

1547

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.0

8.8

100

524

V03AE03

ATC

lanthanum carbonate; oral

8.6

8.8

XQ802

NOMESCO Finland

Epicutan test

2.2

8.8

347

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

8.8

165

1008

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

8.7

135

780

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.7

275

1899

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

8.7

150

894

C09CA06

ATC

candesartan; oral

1.4

8.7

405

3016

QCH05

NOMESCO Finland

Correction of deformity of finger nail

50.2

8.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

8.7

436

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.2

8.7

316

N30.2

ICD-10 Finland

Other chronic cystitis

4.3

8.7

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.6

397

2949

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.6

231

1540

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.6

708

5773

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.6

809

6724

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

8.6

222

1468

KH1AD

NOMESCO Finland

CT of urinary organs

2.3

8.6

279

L60.2

ICD-10 Finland

Onychogryphosis

11.6

8.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

8.6

277

1923

Z2446

NOMESCO Finland

Social worker

1.7

8.6

142

838

JAH01

NOMESCO Finland

Laparoscopy

2.1

8.6

384

A12BA01

ATC

potassium chloride; oral

2.3

8.5

280

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.9

8.5

137

N03AE01

ATC

clonazepam; systemic

1.9

8.5

102

545

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

8.5

461

3524

NH3DG

NOMESCO Finland

Very extensive MRI of foot

27.6

8.5

H3603, E107,

ICD-10 Finland

20.1

8.5

R13

ICD-10 Finland

Dysphagia

1.8

8.5

120

676

M01AX05

ATC

glucosamine; oral

1.5

8.4

290

2038

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

8.4

434

6811B

ICD-9 Finland

Cellulitis and abscess of finger and toe, Toe[PARONYCHIA DIGITORUM PEDIS]

90.4

8.4

J05AB11

ATC

valaciclovir; oral

1.5

8.4

251

1713

C08CA05

ATC

nifedipine; systemic

2.0

8.4

462

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

8.4

166

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

12.8

8.4

P01BA02

ATC

hydroxychloroquine; oral

1.7

8.4

141

836

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.0

8.4

122

SFA10

NOMESCO Finland

One-surface restoration

1.3

8.3

1124

9792

N06AB04

ATC

citalopram; systemic

1.4

8.3

365

2686

L15

ICPC

Knee symptom/complaint

1.4

8.3

427

3231

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

8.3

105

570

A04AA01

ATC

ondansetron; systemic, rectal

1.8

8.3

134

784

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

8.3

471

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.3

225

1504

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

8.3

290

N20.1

ICD-10 Finland

Calculus of ureter

2.2

8.3

303

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

8.2

158

970

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.5

8.2

191

B02.9

ICD-10 Finland

Zoster without complication

1.9

8.2

109

601

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.2

388

2893

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

8.2

310

S21

ICPC

Skin texture symptom/complaint

1.5

8.2

239

1622

R21

ICPC

Throat symptom/complaint

1.4

8.2

444

3390

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

8.2

291

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

8.2

729

6002

L21.0

ICD-10 Finland

Seborrhoea capitis

3.7

8.2

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

3.0

8.2

113

K03.66

ICD-10 Finland

Tooth plaque

1.7

8.1

151

919

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

8.1

147

889

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

8.1

125

723

QDH

NOMESCO Finland

Operations on toe nails

17.2

8.1

RJ630, ,

NOMESCO Finland

17.2

8.1

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

11.7

8.1

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

8.1

241

1645

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

8.0

467

3607

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

8.0

521

4094

H02AB09

ATC

hydrocortisone; systemic

2.4

8.0

218

R06.5

ICD-10 Finland

Mouth breathing

1.6

8.0

177

1127

M79.1

ICD-10 Finland

Myalgia

1.5

8.0

275

1932

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.3

8.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

8.0

163

1017

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.0

380

2837

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

8.0

374

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.7

8.0

159

L30.3

ICD-10 Finland

Infective dermatitis

2.2

8.0

301

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.0

7.9

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

13.1

7.9

SPAT1252

SPAT

Overall medication plan or its review

1.8

7.8

105

582

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

7.8

124

723

M01AX01

ATC

nabumetone; oral

2.1

7.8

344

S01

ICPC

Pain/tenderness of skin

2.0

7.8

440

A10BX01

ATC

guar gum; oral

2.3

7.8

259

3025

Kela drug reimbursment

Calcium carbonate

7.0

7.8

H10

ICD-10 Finland

Conjunctivitis

1.7

7.8

144

877

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

7.8

281

1995

M01AH02

ATC

rofecoxib; oral

1.6

7.7

196

1290

K07.60

ICD-10 Finland

Snapping jaw

1.9

7.7

100

548

XKD00

NOMESCO Finland

Uroflowmetry

1.6

7.7

205

1364

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.9

7.7

L08

ICPC

Shoulder symptom/complaint

1.4

7.6

375

2814

H02BX01

ATC

methylprednisolone, combinations; systemic

2.0

7.6

395

M14.6

ICD-10 Finland

Neuropathic arthropathy

18.4

7.6

RS221, ,

NOMESCO Finland

2.8

7.6

129

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

7.6

181

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.6

140

852

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

7.6

436

3359

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

3.5

7.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

7.5

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

7.5

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

7.5

214

1445

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

7.5

127

754

G04CA02

ATC

tamsulosin; oral

1.4

7.5

299

2161

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

7.5

119

694

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.5

496

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

7.5

181

1179

B01AB10

ATC

tinzaparin; parenteral

1.6

7.5

161

1020

L03

ICPC

Low back symptom/complaint

1.3

7.4

513

4063

L71.8

ICD-10 Finland

Other rosacea

4.4

7.4

R05

ICPC

Cough

1.4

7.4

434

3351

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

7.4

323

2373

W19

ICD-10 Finland

Unspecified fall

1.6

7.4

179

1165

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

3.0

7.4

109

L68.0

ICD-10 Finland

Hirsutism

13.4

7.4

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

7.4

126

751

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.0

7.4

393

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.9

7.3

115

SPAT1283

SPAT

Restricted health certificate

1.4

7.3

364

2736

SPAT1234

SPAT

Support of social functional capacity

1.9

7.3

464

RJ520, ,

NOMESCO Finland

+∞

7.3

J02AC02

ATC

itraconazole; systemic

1.4

7.3

298

2164

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.4

7.3

197

C10AA04

ATC

fluvastatin; oral

1.7

7.3

122

723

D05BB02

ATC

acitretin; oral

2.4

7.3

191

B01AA03

ATC

warfarin; systemic

1.5

7.2

248

1741

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

7.2

127

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

7.2

524

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

7.2

138

848

H02.4

ICD-10 Finland

Ptosis of eyelid

2.3

7.2

223

K05.30

ICD-10 Finland

Periodontitis complex

1.5

7.2

240

1676

R02

ICPC

Shortness of breath/dyspnoea

1.5

7.2

212

1443

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

7.2

321

212

Kela drug reimbursment

Gout

3.1

7.2

A02BA03

ATC

famotidine; systemic

2.2

7.2

262

A52.1

ICD-10 Finland

Symptomatic neurosyphilis

30.1

7.1

G04BD12

ATC

mirabegron; oral

1.6

7.1

172

1119

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.1

7.1

R74

ICPC

Upper respiratory infection acute

1.3

7.1

653

5377

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

20.1

7.1

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

7.1

289

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

7.1

412

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

7.1

184

1218

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

7.1

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.7

7.1

122

729

R55

ICD-10 Finland

Syncope and collapse

1.6

7.1

176

1154

C08DB01

ATC

diltiazem; oral

2.1

7.1

330

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.6

7.1

SFA00

NOMESCO Finland

Small restoration

1.5

7.0

254

1801

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

7.0

344

C09AA05

ATC

ramipril; oral

1.4

7.0

369

2798

M65.3

ICD-10 Finland

Trigger finger

1.9

7.0

449

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

10.1

7.0

M05BA04

ATC

alendronic acid; oral

1.7

7.0

126

761

3AC01, ,

NOMESCO Finland

3.5

7.0

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

7.0

291

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

7.0

278

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

6.9

167

1086

J01MA01

ATC

ofloxacin; systemic

1.7

6.9

128

779

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.9

147

928

A01AB04

ATC

amphotericin B; local oral

2.0

6.9

381

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

6.9

132

811

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

6.9

561

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

6.9

190

C09DA01

ATC

losartan and diuretics; oral

1.6

6.9

169

1105

SDA03

NOMESCO Finland

Periodontal treatment

1.3

6.9

756

6370

N03AG01

ATC

valproic acid; systemic, rectal

1.7

6.9

117

697

F32.8

ICD-10 Finland

Other depressive episodes

2.6

6.9

154

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.9

173

1138

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.5

6.9

160

H25.8

ICD-10 Finland

Other senile cataract

1.6

6.9

141

883

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

6.8

121

728

A10AD05

ATC

insulin aspart; parenteral

2.8

6.8

114

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

6.8

203

H92.0

ICD-10 Finland

Otalgia

1.7

6.8

120

721

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

6.8

418

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

6.8

281

R04.0

ICD-10 Finland

Epistaxis

1.7

6.8

116

692

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.8

275

1995

M54.8

ICD-10 Finland

Other dorsalgia

1.9

6.7

441

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.7

203

1388

XCD20

NOMESCO Finland

Photoangiography of eye

3.1

6.7

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

6.7

470

A10BB01

ATC

glibenclamide; oral

2.3

6.7

217

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

6.7

309

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

6.7

413

Z50.1

ICD-10 Finland

Other physical therapy

1.8

6.7

485

M20.5

ICD-10 Finland

Other deformities of toe(s) (acquired)

3.9

6.7

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.4

6.7

M01AX17

ATC

nimesulide; oral

1.4

6.7

383

2944

D01AC02

ATC

miconazole; topical

1.7

6.7

129

795

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

6.7

365

RJ120, ,

NOMESCO Finland

22.6

6.7

PFP99

NOMESCO Finland

Percutaneous plastic repair of artery of lower leg

22.6

6.7

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.9

6.6

105

L73.2

ICD-10 Finland

Hidradenitis suppurativa

6.4

6.6

R5110, ,

SPAT

1.8

6.6

101

583

UJD02

NOMESCO Finland

Gastroscopy

1.9

6.6

387

A03FA02

ATC

cisapride; oral, rectal

1.7

6.6

113

674

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

6.6

1044

9176

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.6

398

3084

NHS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of ankle or foot

12.3

6.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

6.6

374

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.8

6.5

117

I50

ICD-10 Finland

Heart failure

2.4

6.5

176

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.5

6.5

164

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

6.5

172

1143

WX722

NOMESCO Finland

PEEP

1.9

6.5

425

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

6.5

239

1701

ZZA00

NOMESCO Finland

Split skin graft

2.3

6.5

208

R4180, ,

SPAT

3.7

6.5

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

6.5

102

595

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

6.2

6.5

SPAT1285

SPAT

Provision of consultation response

1.8

6.5

528

SPAT1325

SPAT

Vaccination

1.3

6.5

570

4661

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

6.5

138

873

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

6.4

165

R03BA01

ATC

beclometasone; inhalant

1.5

6.4

228

1611

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

6.4

441

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

6.4

189

1286

M01AB05

ATC

diclofenac; systemic, rectal

1.3

6.4

1264

11380

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.4

6.4

L01BB01, ,

ATC

14.3

6.4

TAB00

NOMESCO Finland

Lumbar puncture

1.8

6.4

471

E000007, ,

ATC

1.7

6.4

102

597

G01AF05

ATC

econazole; vaginal

1.7

6.4

112

673

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.4

226

1597

R03DC03

ATC

montelukast; oral

1.4

6.4

303

2258

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

6.4

116

704

C09BA02

ATC

enalapril and diuretics; systemic

1.7

6.4

111

666

SPAT1360

SPAT

Extensive global examination

1.7

6.4

111

666

R01AD12

ATC

fluticasone furoate; nasal

1.3

6.4

617

5106

SFA30

NOMESCO Finland

Three-surface restoration

1.3

6.4

776

6608

M05BA07

ATC

risedronic acid; oral

2.2

6.3

223

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

6.3

116

706

68104

ICD-8 Finland

Cellulitis of finger and toe, Unguis incarnatus infectus

11.0

6.3

M54.1

ICD-10 Finland

Radiculopathy

1.9

6.3

366

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

6.3

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.7

6.3

114

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

6.3

511

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.0

6.3

311

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

6.3

395

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

6.2

284

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.4

6.2

180

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

6.2

360

A10BK01

ATC

dapagliflozin; oral

1.7

6.2

111

670

XF404

NOMESCO Finland

Ambulatory ECG

1.6

6.2

135

857

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

6.2

171

1148

NH3BG

NOMESCO Finland

MRI of foot

5.0

6.2

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

5.0

6.2

TK810

NOMESCO Finland

Hemofiltration

5.0

6.2

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.0

6.2

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

6.2

190

1306

L71.9

ICD-10 Finland

Rosacea, unspecified

2.8

6.2

104

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

6.2

485

3903

R06.2

ICD-10 Finland

Wheezing

1.8

6.2

455

K92.1

ICD-10 Finland

Melaena

1.9

6.2

426

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.4

6.2

175

K07

ICPC

Swollen ankles/oedema

1.9

6.1

355

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.4

6.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

6.1

246

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

6.1

182

1242

M22.4

ICD-10 Finland

Chondromalacia patellae

2.0

6.1

307

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.9

6.1

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

6.1

493

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

6.1

103

613

P04

ICPC

Feeling/behaving irritable/angry

3.8

6.1

A10AB06

ATC

insulin glulisine; parenteral

3.0

6.1

K30

ICD-10 Finland

Functional dyspepsia

1.5

6.1

189

1302

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

6.1

371

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.6

6.1

S82.0

ICD-10 Finland

Fracture of patella

2.6

6.0

128

N48.1

ICD-10 Finland

Balanoposthitis

2.1

6.0

254

AN1

Coronary angiography

1.6

6.0

143

928

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.5

6.0

140

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

6.7

6.0

G63.2

ICD-10 Finland

Diabetic polyneuropathy

6.7

6.0

RS340, ,

NOMESCO Finland

10.0

6.0

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.5

6.0

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.3

6.0

177

I84.3

ICD-10 Finland

External thrombosed hemorrhoids

3.3

6.0

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

6.0

H26.2

ICD-10 Finland

Complicated cataract

2.9

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

488

1989

2.86

82.60

2.2

1.6

—

(3000494) Fungus identified in Specimen by Culture

431

2020

2.41

52.67

1.7

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1333

9885

1.87

43.52

6.5

4.8

7.05

6.62

mmol/l

8.06

1257

9209

(3023368) Bacteria identified in Blood by Culture

692

4200

1.94

42.12

5.2

4.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

744

4715

1.87

39.08

4.9

3.9

15.96

9.33

mg/mmol

2.00

509

3020

(3042936) Bacteria identified in Isolate by Culture

436

2308

2.11

38.55

2.6

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1119

8067

1.78

37.99

10.8

6.6

1.21

mmol/l

0.71

972

6880

(3004789) Transferrin [Mass/volume] in Serum or Plasma

432

2291

2.10

37.95

4.1

2.4

2.31

2.36

g/l

1.26

406

2116

(3012516) Albumin [Mass/volume] in Urine

713

4492

1.86

37.94

4.3

3.3

161.21

332.84

mg/l

1.04

502

2922

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1033

7318

1.77

36.89

9.3

6.1

1.21

mmol/l

0.31

959

6705

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

658

4096

1.86

36.03

3.3

3.0

1720.79

1147.05

ng/l

1.26

566

3403

(3022948) Iron [Moles/volume] in Serum or Plasma

452

2488

2.02

35.67

4.1

2.4

12.11

13.80

umol/l

6.12

428

2318

(3024561) Albumin [Mass/volume] in Serum or Plasma

992

7007

1.75

35.29

6.8

4.8

35.66

36.18

g/l

2.12

930

6554

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

401

2128

2.08

34.92

4.2

2.5

21.41

23.87

3.40

356

1835

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

992

7068

1.73

33.74

3.0

2.3

74.64

75.09

nmol/l

0.20

888

6422

(3009508) Creatinine [Moles/volume] in Urine

775

5153

1.77

33.65

4.2

3.3

7.52

7.99

mmol/l

1.86

662

4434

(3026493) Urate [Moles/volume] in Serum or Plasma

679

4354

1.81

33.27

3.8

2.6

2329.75

4816.02

umol/l

1.57

600

3887

(3000991) Gas panel - Venous blood

288

1367

2.27

33.16

8.5

9.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

642

4060

1.82

32.87

2.8

2.1

2.91

2.89

mg/l

0.10

562

3466

(3022217) INR in Platelet poor plasma by Coagulation assay

998

7203

1.70

31.76

16.2

12.7

1.18

1.20

inr

0.45

285

2164

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1607

13195

1.78

31.74

9.9

7.2

78.68

77.47

u/l

0.56

1542

12450

(3021447) Carbon dioxide [Partial pressure] in Venous blood

303

1504

2.17

31.17

6.1

4.2

5.91

5.86

kpa

0.30

296

1457

(3013115) Eosinophils [#/volume] in Blood

1202

9181

1.67

30.33

8.5

6.3

0.20

0.19

e9/l

1.14

1078

8110

(3002032) Base excess in Venous blood by calculation

298

1493

2.15

29.87

6.4

4.2

1.63

1.92

mmol/l

0.70

267

1235

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1141

8638

1.66

29.46

7.1

6.0

10.31

11.36

umol/l

3.60

1104

8205

(3020779) Urea [Moles/volume] in Serum or Plasma

286

1422

2.16

29.20

15.1

8.2

10.97

8.71

mmol/l

6.02

279

1360

(3006315) Basophils [#/volume] in Blood

1164

8882

1.65

28.93

8.3

6.0

0.04

e9/l

0.12

1028

7733

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

859

6077

1.67

28.62

4.2

3.3

45.67

44.42

ng/l

0.03

593

3852

(3001604) Monocytes [#/volume] in Blood

1161

8872

1.65

28.54

8.3

6.0

0.58

0.57

e9/l

0.86

1025

7729

(3018418) pH of Serum or Plasma

708

4762

1.71

28.49

6.8

3.9

7.39

7.40

1.68

135

943

(3003458) Phosphate [Moles/volume] in Serum or Plasma

387

2171

1.95

28.34

12.5

6.1

1.10

1.06

mmol/l

2.57

367

2028

(40760892) CBC W Ordered Manual Differential panel - Blood

1100

8326

1.64

27.83

8.7

6.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

432

2540

1.87

27.33

2.0

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

1185

9163

1.63

27.28

8.3

6.0

1.87

1.96

e9/l

1.21

1069

8168

(3024354) Oxygen [Partial pressure] in Venous blood

257

1259

2.18

27.17

4.9

3.6

4.86

4.71

kpa

0.40

249

1215

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

891

6428

1.64

27.10

2.2

1.9

94.92

96.63

pmol/l

0.45

463

3356

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

755

5230

1.67

26.87

3.7

2.5

52.88

74.19

u/l

0.78

698

4855

(3013650) Neutrophils [#/volume] in Blood by Automated count

1291

10219

1.63

26.82

11.5

9.1

4.26

4.01

e9/l

3.38

1151

8942

(40758558) Short blood count panel - Blood

658

4407

1.70

26.53

8.4

6.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

244

1191

2.18

25.99

6.6

4.1

122.49

82.38

ng/l

4.54

216

1058

(3031040) Bacteria [#/volume] in Urine by Automated count

1366

11036

1.62

25.46

6.0

4.1

1161.81

1987.55

e6/l

0.37

143

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

704

4857

1.66

25.08

2.6

2.2

160.65

266.83

u/l

2.40

666

4596

(3026008) Bacteria identified in Urine by Culture

682

4709

1.65

24.01

3.9

2.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

268

1402

2.04

23.71

6.7

7.9

1.27

1.40

mmol/l

1.60

263

1363

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

200

937

2.25

23.51

1.7

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2007

18150

2.08

23.49

21.2

12.4

21.67

22.84

mg/l

0.96

1697

14044

(3000850) Epithelial cells [#/volume] in Urine

521

3383

1.71

23.06

3.5

2.5

5.30

6.28

e6/l

0.92

476

3039

(3012095) Magnesium [Moles/volume] in Serum or Plasma

431

2668

1.76

22.59

5.1

3.8

0.81

0.82

mmol/l

0.58

403

2528

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1011

7767

1.55

22.17

4.0

2.8

122.77

116.79

ug/l

0.45

944

7229

(40761535) Cells panel - Urine sediment

240

1239

2.05

21.96

6.2

3.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1523

12857

1.58

21.61

5.5

3.9

12.68

10.66

mm/h

6.09

1419

11945

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

222

1123

2.09

21.44

1.9

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

615

4248

1.62

21.13

1.4

1.3

1.48

1.74

u/ml

0.30

176

1125

(3006504) Eosinophils/100 leukocytes in Blood

1066

8359

1.53

20.83

8.5

6.2

2.90

2.83

0.43

1003

7829

(3010375) cycloSPORINE [Mass/volume] in Blood

5.27

20.82

31.4

28.4

103.16

130.51

ug/l

1.43

(3019069) Monocytes/100 leukocytes in Blood

1071

8411

1.53

20.75

8.9

6.5

8.45

8.53

0.37

1007

7896

(3044640) Blood type and Crossmatch panel - Blood

729

5273

1.57

20.47

2.8

2.3

—

(3022096) Basophils/100 leukocytes in Blood

1036

8103

1.52

20.30

8.5

6.3

0.66

0.68

0.33

971

7586

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

585

4026

1.61

20.26

2.8

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1991

18147

1.92

19.87

23.1

14.0

139.56

139.65

mmol/l

0.97

1960

17662

(3019309) Folate [Moles/volume] in Red Blood Cells

429

2740

1.70

19.85

1.8

1.7

1310.67

1186.49

nmol/l

1.68

323

2081

(3023103) Potassium [Moles/volume] in Serum or Plasma

1996

18211

1.93

19.80

23.2

14.1

3.98

3.96

mmol/l

3.87

1962

17692

(3037467) Urinalysis macro (dipstick) panel - Urine

1414

11862

1.53

19.53

6.0

4.0

—

(3018010) Neutrophils/100 leukocytes in Blood

1078

8558

1.50

19.33

8.3

6.0

57.78

56.42

3.46

1020

8046

(3002030) Lymphocytes/100 leukocytes in Blood

1091

8689

1.50

19.22

8.7

6.2

27.30

28.86

5.05

1031

8178

(3026250) Tacrolimus [Mass/volume] in Blood

4.70

19.17

37.4

34.1

7.36

7.61

ug/l

0.30

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1013

7960

1.50

18.96

2.9

2.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

298

1737

1.83

18.88

7.1

8.3

5.04

5.11

kpa

0.58

288

1667

(3027801) Oxygen [Partial pressure] in Arterial blood

298

1738

1.83

18.85

7.1

8.3

12.39

12.63

kpa

0.24

289

1671

(3018095) Leukocytes [#/volume] in Urine

785

5857

1.53

18.78

5.0

3.6

53.55

95.42

e6/l

1.61

589

4052

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

303

1780

1.81

18.71

1.9

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

557

3851

1.60

18.70

5.3

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

635

4528

1.56

18.65

4.3

3.0

0.28

0.38

e6/l

1.64

513

3394

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

157

732

2.23

18.62

4.5

3.1

1.28

1.30

0.06

157

726

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

199

1019

2.05

18.55

4.2

3.6

1.58

1.64

mmol/l

0.08

144

756

(3003396) Base excess in Arterial blood by calculation

296

1737

1.81

18.32

7.2

8.4

0.77

1.08

mmol/l

0.60

241

1383

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

205

1068

2.01

18.21

4.5

3.6

5.20

5.16

kpa

0.27

197

1022

(3009343) pH of Capillary blood

204

1061

2.02

18.21

4.4

3.6

7.41

0.05

134

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

304

1804

1.79

18.12

2.0

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

152

709

2.23

18.01

4.2

3.1

0.65

0.00

152

704

(3016502) Oxygen saturation in Arterial blood

270

1548

1.85

18.01

7.5

8.8

96.09

95.85

0.36

264

1499

(3009261) Glucose [Presence] in Urine by Test strip

1070

8564

1.48

17.92

5.3

3.4

0.01

0.00

estimate

0.06

181

1545

(3021601) Nitrite [Presence] in Urine by Test strip

1061

8490

1.48

17.72

6.8

4.6

0.00

estimate

0.50

194

1619

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1830

16409

1.65

17.66

5.5

4.5

1.84

2.02

mu/l

1.04

1701

15186

(3021960) Folate [Moles/volume] in Serum or Plasma

519

3573

1.59

17.59

1.7

1.5

19.85

20.73

nmol/l

0.69

445

3063

(3015736) pH of Urine

892

6914

1.48

17.39

4.8

3.1

5.83

5.85

0.09

607

(36304419) Bacteria [Presence] in Urine

618

4464

1.53

16.81

4.2

3.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

558

3942

1.55

16.79

2.0

1.8

1.16

1.11

mg/l

0.15

423

2924

(3002582) Erythrocytes [#/volume] in Urine

671

4938

1.51

16.71

4.4

3.1

31.44

94.71

e6/l

1.57

547

3750

(3035350) Ketones [Presence] in Urine by Test strip

1054

8498

1.46

16.49

5.3

3.4

0.00

estimate

0.99

203

1696

(3015377) Calcium [Moles/volume] in Serum or Plasma

736

5536

1.49

16.42

3.9

3.2

2.35

mmol/l

0.63

646

4937

(3027945) Reticulocytes/100 erythrocytes in Blood

284

1705

1.76

16.19

3.3

3.0

1.81

1.75

0.38

247

1531

(3007164) IgA [Mass/volume] in Serum or Plasma

535

3776

1.55

16.07

1.5

2.29

2.33

g/l

0.19

325

2344

(40768804) Tissue Pathology biopsy report

850

6604

1.46

15.99

2.3

2.0

—

(3037522) Nuclear Ab [Titer] in Serum

366

2363

1.66

15.96

1.4

1.3

495.70

518.97

titre

0.08

467

(3026782) Osmolality of Urine

474

3280

1.57

15.47

4.0

2.8

528.59

549.64

mosm/kgh2o

1.29

419

2822

(3033658) Prothrombin time (PT) actual/Normal

591

4307

1.51

15.16

5.2

4.0

92.39

91.95

0.15

577

4193

(3018677) aPTT in Platelet poor plasma by Coagulation assay

380

2515

1.62

14.94

2.8

2.3

30.47

29.64

1.63

372

2436

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

770

5933

1.46

14.85

3.9

3.3

28.26

32.24

u/l

5.80

724

5639

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1779

16036

1.55

14.70

7.7

5.1

42.22

39.15

mmol/mol

23.13

1684

14992

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1561

13741

1.46

14.14

4.5

3.8

14.77

14.70

pmol/l

0.49

1437

12575

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

368

2.48

13.91

11.6

6.2

269.14

550.35

iu/ml

0.56

(40761511) CBC panel - Blood by Automated count

2039

19085

1.82

13.67

18.8

11.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

399

2753

1.55

12.97

3.5

2.7

1.24

1.07

e6/l

0.37

251

1520

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2059

19376

1.84

12.89

14.1

9.5

28.12

27.97

u/l

0.12

2010

18743

(3048689) Calprotectin [Mass/mass] in Stool

347

2328

1.58

12.74

2.4

2.5

179.03

131.06

ug/g

0.84

271

1856

(3009445) Proteinase 3 Ab [Units/volume] in Serum

135

689

2.02

12.69

1.5

1.6

10.51

10.77

u/ml

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1844

16896

1.53

12.68

17.4

11.3

84.08

86.43

ml/min/173m2

3.37

1561

13740

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

174

969

1.86

12.65

8.9

10.3

0.68

0.69

0.11

174

963

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

175

977

1.86

12.62

8.9

10.1

1.35

1.39

0.20

175

972

(3036481) Cortisol [Moles/volume] in Serum or Plasma

264

1665

1.66

12.45

2.5

2.0

366.65

374.91

nmol/l

0.30

241

1537

(3021589) Normoblasts [#/volume] in Blood

961

7882

1.39

12.37

12.5

9.2

0.00

e9/l

0.00

802

6446

(3014007) Fractional oxyhemoglobin in Arterial blood

173

971

1.85

12.27

9.1

10.3

94.18

94.05

0.13

173

965

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

166

924

1.86

12.09

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

248

1556

1.67

11.92

2.4

2.3

0.23

0.22

g/l

1.49

238

1457

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

273

1756

1.63

11.90

4.8

4.3

235.51

241.41

u/l

0.36

256

1665

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

213

1290

1.72

11.67

2.7

2.3

6.54

7.70

ug/l

0.35

184

1146

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

397

2800

1.51

11.55

1.3

1.2

18.90

11.18

u/ml

0.92

167

1126

(3023520) Reticulocytes [#/volume] in Blood

204

1230

1.73

11.36

3.5

2.9

72.29

71.77

e9/l

0.08

157

943

(3019060) Gas panel - Arterial blood

171

983

1.80

11.22

5.2

5.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

119

609

2.01

11.12

2.1

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

581

4461

1.41

10.72

6.3

3.7

0.00

0.01

estimate

1.54

186

1565

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

401

2874

1.48

10.72

3.2

2.9

2.44

mmol/l

0.03

357

2535

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

812

6591

1.37

10.69

5.7

3.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

114

584

2.00

10.64

2.5

2.1

2.62

1.79

ug/l

0.33

103

519

(3052851) Hemolysis interference index of Serum or Plasma

482

2.10

10.60

3.3

2.9

—

(3020891) Body temperature

117

606

1.98

10.58

8.2

4.7

—

(3022313) Gas panel - Capillary blood

143

794

1.86

10.51

4.5

3.7

—

(3042733) HLA Ab [Presence] in Serum

3.96

10.31

4.3

4.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

289

1953

1.55

10.17

10.2

6.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

453

3365

1.43

9.98

1.8

1.6

48320853.86

33075729.45

pmol/l

0.18

387

2842

(3017181) Myelocytes/100 leukocytes in Blood

222

1419

1.63

9.89

4.9

4.3

1.27

0.97

0.54

472

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

122

660

1.90

9.73

1.8

1.9

1.69

1.48

g/l

1.53

108

577

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

107

556

1.97

9.61

2.0

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

204

1286

1.65

9.60

3.0

2.4

62.46

70.91

ml/min/173m2

1.89

482

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

376

2.17

9.40

2.6

2.2

103.76

93.34

ug/min

0.12

224

(4146454) Self-monitoring of blood glucose

156

2.86

9.40

3.6

2.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

283

1937

1.53

9.38

2.9

5.51

7.71

umol/l

3.70

243

1677

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

419

3102

1.43

9.34

4.7

3.5

606.48

523.80

ng/l

0.12

318

2258

(3005719) IgG [Mass/volume] in Serum or Plasma

216

1391

1.61

9.33

3.3

2.8

10.46

10.44

g/l

0.02

202

1271

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

404

2978

1.44

9.22

1.3

1.2

29.38

28.46

iu/ml

0.04

113

956

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

244

1624

1.56

9.17

3.6

2.4

33.00

68.44

u/l

0.64

207

1395

(3020630) Protein [Mass/volume] in Serum or Plasma

188

1177

1.65

9.09

2.1

2.7

65.58

66.84

g/l

1.62

175

1082

(3019150) Specific gravity of Urine by Refractometry

489

3741

1.39

9.01

6.0

3.6

1.02

kg/l

0.82

531

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.40

8.90

1.9

1.4

1.01

1.21

nmol/l

0.42

(40768797) Stomach Pathology biopsy report

323

2299

1.47

8.84

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

308

2.25

8.77

1.5

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

123

694

1.82

8.62

4.9

3.9

24.68

24.82

mmol/l

0.21

114

654

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

169

1044

1.67

8.61

7.6

8.6

24.89

24.93

mmol/l

0.05

169

1037

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1914

18000

1.45

8.41

5.5

4.4

2.66

2.83

mmol/l

14.37

1796

16783

(40768446) Kidney Pathology biopsy report

3.58

8.40

1.7

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

282

2.27

8.37

7.2

3.2

—

(3044889) 12 lead EKG panel

1347

12028

1.30

8.26

4.2

3.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

206

1351

1.58

8.25

4.8

4.4

0.15

0.10

0.38

402

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

103

558

1.89

8.22

1.5

1.6

96.00

144.17

titre

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.77

8.11

6.1

6.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

484

1.94

8.02

1.6

1.5

263.21

296.26

ug/g

0.97

280

(3025941) Bacteria identified in Stool by Culture

160

993

1.66

8.02

1.4

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

354

2614

1.42

7.92

3.7

2.9

3.69

2.69

e6/l

0.87

206

1390

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1887

17753

1.41

7.78

5.0

4.1

4.53

4.72

mmol/l

14.67

1791

16660

(3007461) Platelets [#/volume] in Blood

2132

20596

1.84

7.77

30.0

18.1

255.26

252.76

e9/l

0.97

2096

20067

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1878

17658

1.41

7.73

5.0

4.0

1.37

1.44

mmol/l

10.69

1764

16475

(3035941) MCH [Entitic mass]

2133

20613

1.84

7.70

29.9

18.0

30.08

30.21

2.90

2113

20332

(3024731) MCV [Entitic volume]

2133

20614

1.84

7.69

29.9

18.0

90.30

90.38

0.31

2113

20336

(3026361) Erythrocytes [#/volume] in Blood

2133

20617

1.84

7.64

30.1

18.1

4.54

4.58

e12/l

2.86

2092

20046

(3017817) Protein [Mass] in Urine collected for unspecified duration

140

2.74

7.62

3.0

2.2

—

(3010813) Leukocytes [#/volume] in Blood

2133

20619

1.83

7.61

30.1

18.1

6.86

6.65

e9/l

4.87

2096

20042

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1402

12652

1.29

7.59

3.4

3.1

52.38

46.48

u/l

1.67

1328

11925

(3017143) Hepatitis C virus Ab [Presence] in Serum

331

2433

1.42

7.58

2.0

1.6

—

(4035726) Immunohistochemistry procedure

206

1378

1.55

7.56

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

348

2.07

7.56

1.4

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

2133

20624

1.83

7.53

30.2

18.2

135.55

137.53

g/l

7.42

2112

20341

(3009542) Hematocrit [Volume Fraction] of Blood

2130

20591

1.81

7.45

30.1

18.2

40.59

40.95

0.76

2047

19421

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

421

1.96

7.34

1.5

1.3

—

(36660697) Celiac disease serology panel - Serum

223

1529

1.51

7.31

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1815

17012

1.36

7.26

4.6

3.6

1.45

1.33

mmol/l

7.84

1694

15781

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

198

2.40

7.20

1.3

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

194

1299

1.54

7.10

4.9

4.1

0.55

0.66

0.15

403

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

194

2.40

7.04

1.3

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

167

1084

1.58

7.00

1.7

1.9

1.37

1.34

g/l

0.08

149

1000

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

134

824

1.67

6.99

9.1

11.5

—

(3025159) Blasts/100 leukocytes in Blood

192

1289

1.54

6.94

4.9

4.4

0.00

0.37

0.81

334

(3013512) EKG study

558

4516

1.31

6.88

4.2

3.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

197

2.36

6.82

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

469

1.87

6.78

2.7

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

463

1.87

6.73

3.0

3.7

0.30

0.35

u/ml

0.64

262

(3021901) Oxygen saturation in Capillary blood

284

2.11

6.62

4.1

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

1706

15917

1.31

6.52

23.8

15.1

14.67

14.80

0.16

1685

15617

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

195

2.33

6.51

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

195

2.33

6.51

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

196

2.32

6.44

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1808

17017

1.33

6.41

5.0

4.1

6.24

5.86

mmol/l

14.55

1668

15638

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

487

1.82

6.34

2.0

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

150

973

1.58

6.33

1.8

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

243

2.17

6.31

1.2

—

(3024932) HLA-DR beta [Type]

3.31

6.14

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1442

13222

1.26

6.06

3.5

3.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

125

786

1.63

6.01

3.4

2.8

0.48

0.25

e6/l

0.68

119

763

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

161

1076

1.53

5.97

3.2

3.3

4.47

4.59

pmol/l

0.67

141

960

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

550

4532

1.28

5.79

1.8

1.6

1.50

1.42

mmol/l

0.89

479

3888

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

411

3259

1.32

5.77

1.9

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.92

5.71

1.1

0.70

8.35

u/ml

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

2.49

5.70

2.1

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

2.49

5.70

2.1

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

2.49

5.70

2.1

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

268

2.04

5.64

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

537

1.72

5.58

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

123

786

1.60

5.56

2.2

1.9

37.11

39.45

u/l

0.62

114

711

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

553

1.71

5.55

1.4

1.3

—

(40768443) Skin Pathology biopsy report

105

646

1.66

5.52

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

355

1.89

5.49

2.9

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

542

1.71

5.41

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

155

1051

1.51

5.39

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

439

1.78

5.33

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.19

5.32

4.0

3.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

156

2.33

5.27

1.2

1.1

79.94

57.87

u/l

0.36

144

(3024471) HLA-A [Type]

3.06

5.22

1.1

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

540

1.69

5.22

5.9

5.1

1.66

1.38

mg/l

1.80

506

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

503

1.72

5.18

2.6

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

406

1.80

5.18

1.8

3.6

33.41

39.78

mg/l

0.35

320

(3034860) Kappa light chains.free [Mass/volume] in Serum

406

1.80

5.18

1.8

3.6

50.45

64.50

mg/l

0.39

321

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

284

1.96

5.18

2.1

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

172

1202

1.47

5.17

1.4

1.3

335.39

220.57

u/ml

0.44

155

1114

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

399

1.81

5.17

1.8

3.6

1.30

1.67

ratio

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

185

1312

1.45

5.15

7.1

3.7

1.22

1.23

mmol/l

0.58

171

1149

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

364

1.84

5.11

2.0

1.6

103.16

122.77

u/ml

0.65

(3051651) Icteric interference index of Serum or Plasma

104

2.62

5.06

3.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

395

1.80

5.03

5.8

2.0

0.95

0.84

nmol/l

0.52

339

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

120

782

1.56

5.02

2.5

2.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

323

1.88

5.01

1.1

107.77

1687.82

iu/ml

0.52

(40760888) Immunoglobulin light chains.free panel - Serum

309

1.90

5.00

1.7

3.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.05

4.94

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

550

1.66

4.89

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

436

1.75

4.89

1.4

1.3

202.19

250.79

u/ml

1.33

265

(3036489) Thrombin time

107

684

1.59

4.86

2.8

2.5

21.71

21.26

0.19

612

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

182

2.16

4.82

1.9

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

453

1.72

4.82

1.4

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

223

2.04

4.77

2.2

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

203

2.09

4.76

1.9

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

609

1.62

4.75

4.2

5.9

1.75

1.67

0.36

571

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.68

4.75

1.4

1.1

97.50

77.37

u/l

0.45

(42529406) Shigella sp [Presence] in Stool by Culture

555

1.65

4.74

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

483

4006

1.26

4.72

1.7

1.6

—

(3022145) Colonoscopy Study observation

247

1873

1.36

4.67

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.17

4.65

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.35

4.60

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

292

1.87

4.48

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

155

2.21

4.47

3.4

3.2

—

(3029075) Extractable nuclear Ab panel - Serum

3.28

4.47

1.1

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

635

1.59

4.46

1.3

1.2

0.29

0.77

u/ml

0.60

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

273

1.89

4.37

2.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

273

1.89

4.37

2.4

1.7

—

(3037121) Protein [Mass/volume] in Urine

591

1.60

4.37

4.6

3.5

0.28

0.30

g/l

0.08

274

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

400

1.72

4.29

2.3

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.97

4.28

2.8

2.3

58.31

72.22

ug/l

0.37

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

341

1.78

4.27

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

341

1.78

4.27

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

166

1197

1.42

4.26

3.0

2.8

251.84

180.53

ng/l

1.09

153

1087

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.05

4.24

1.2

1.0

98.63

91.15

—

(3035637) Corticotropin [Mass/volume] in Plasma

206

2.01

4.22

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

581

1.59

4.20

1.7

1.6

0.05

0.13

iu/ml

0.53

107

(4200892) Spirometry reversibility

162

1168

1.42

4.16

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

160

2.14

4.16

2.1

1.8

—

(40768441) Liver Pathology biopsy report

134

2.26

4.16

1.3

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

443

1.67

4.13

1.4

1.2

13.70

47.45

u/ml

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

154

1103

1.43

4.11

1.3

41.45

50.84

au/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

2.26

4.06

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

393

1.70

4.01

2.1

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

10.03

4.01

4.6

5.3

516.14

425.86

umol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

124

2.27

3.97

1.2

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

606

1.56

3.95

4.5

6.0

0.81

0.92

2.07

569

(3002256) Pathology report gross observation

258

2020

1.31

3.94

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

125

2.26

3.90

1.2

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

389

1.69

3.89

2.3

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.51

3.88

1.3

1.1

20.86

14.27

u/l

0.69

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

199

1.98

3.88

2.4

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

199

1.98

3.88

2.4

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

413

1.67

3.85

1.4

1.2

5.45

10.33

u/ml

0.66

(3045414) Leukocytes [Presence] in Urine

108

732

1.50

3.84

2.2

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

315

1.76

3.84

2.0

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

111

757

1.49

3.84

1.1

—

0.89

—

(3023183) Ammonium ion [Moles/volume] in Plasma

368

1.70

3.83

2.1

3.2

30.61

35.60

umol/l

1.35

337

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

207

1.95

3.83

1.5

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.69

3.82

1.1

5.4

50.62

83.17

mg/l

1.54

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

164

1204

1.39

3.82

2.4

22.14

22.03

au/ml

0.00

102

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

243

1.87

3.80

1.7

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.84

3.69

1.8

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.66

3.68

1.9

2.5

0.02

0.01

g/l

0.10

373

(3003181) Sodium [Moles/volume] in Urine

253

1.84

3.68

1.4

64.66

64.99

mmol/l

0.02

207

(3006184) Hemoglobin [Mass/volume] in Capillary blood

365

1.69

3.67

2.7

2.2

129.33

131.67

g/l

0.28

277

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

748

1.48

3.67

1.4

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.39

3.65

1.5

1.4

30.00

17.64

u/ml

—

(3019225) pH of Specimen

200

1528

1.34

3.63

7.8

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

374

1.68

3.62

1.7

1.8

17033.93

13477.70

e6/l

0.30

277

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

406

1.64

3.59

1.4

1.2

5.59

2.68

u/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

207

1593

1.33

3.58

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

130

2.17

3.58

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

2.17

3.58

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

130

2.17

3.58

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

130

2.17

3.58

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

130

2.17

3.58

1.3

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

354

1.68

3.53

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

2.82

3.52

1.4

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

131

2.15

3.51

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.90

3.46

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

341

1.69

3.45

1.4

1.2

21.84

51.96

u/ml

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

187

1.94

3.44

1.6

1.7

64.89

61.14

0.24

121

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

411

1.62

3.43

1.6

6481.76

1151.63

e6/l

0.42

334

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

411

1.62

3.43

1.5

195.22

21.25

e6/l

0.48

318

(3023419) Bacteria identified in Sputum by Culture

230

1.84

3.43

2.7

3.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

320

1.70

3.39

2.0

5.22

mmol/24h

0.00

280

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

1.55

3.37

1.8

2.4

3.82

3.56

g/l

0.66

483

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

1.55

3.37

1.8

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

1.55

3.37

1.8

2.4

7.22

7.26

g/l

0.10

483

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

492

1.56

3.37

1.8

2.4

9.84

10.09

g/l

0.23

450

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.84

3.35

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

269

1.76

3.33

1.1

1.2

—

(3034426) Prothrombin time (PT)

2.55

3.29

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

601

1.50

3.27

1.7

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

144

1064

1.38

3.26

1.4

1.3

—

(1616796) Gas panel - Central venous blood

355

1.65

3.24

4.7

3.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

220

1.83

3.24

1.1

102.45

96.12

0.85

211

(3024980) IgG subclass 4 [Mass/volume] in Serum

317

1.69

3.23

1.2

1.7

0.57

0.79

g/l

1.48

244

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

287

1.72

3.22

2.4

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

379

1.63

3.22

1.6

1.5

—

(3003338) MCHC [Mass/volume]

1691

16152

1.20

3.21

26.3

15.6

332.00

333.60

g/l

6.30

1682

16029

(3027135) IgG subclass 1 [Mass/volume] in Serum

185

1.91

3.20

1.2

1.3

6.12

6.99

g/l

0.83

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

185

1.91

3.20

1.2

1.3

0.46

0.40

g/l

0.35

129

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

164

1.97

3.19

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

211

1657

1.30

3.18

3.8

3.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.74

3.15

2.5

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.74

3.15

2.0

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

186

1.90

3.15

1.2

1.3

2.99

2.89

g/l

0.15

129

(3008757) Leukocyte morphology finding [Identifier] in Blood

172

1.93

3.14

4.5

3.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

230

1.80

3.13

1.1

1.2

—

(4062490) Immunoglobulin typing, IgG

187

1.89

3.11

1.2

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

246

1.76

3.08

2.2

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

479

4142

1.20

3.04

2.3

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

301

1.68

3.00

1.3

1.2

2.41

4.29

u/ml

1.35

133

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

444

1.55

2.95

1.9

2.6

0.67

0.91

g/l

0.33

395

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.65

2.79

1.2

1.4

95.29

90.60

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

101

1385

0.72

2.75

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.32

2.74

4.3

3.7

—

(3017569) Oxygen content in Arterial blood

2.37

2.72

2.4

2.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

413

1.54

2.71

2.0

2.4

38.45

38.49

g/l

0.02

372

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.25

2.70

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.51

2.70

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.22

2.68

1.3

1.9

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.76

2.67

17.2

7.3

5.03

7.13

mmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

239

1952

1.25

2.66

5.4

4.1

33.18

31.62

1.17

170

1364

(3000330) Specific gravity of Urine by Test strip

107

782

1.39

2.64

4.7

3.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

147

1129

1.32

2.64

1.3

—

(1761868) Lipid panel - Serum or Plasma

631

7011

0.86

2.62

3.0

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

244

1.69

2.60

2.2

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

298

1.62

2.60

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

306

1.61

2.59

1.3

1.2

1.74

3.49

u/ml

1.11

(3020874) Milk IgE Ab [Units/volume] in Serum

107

2.07

2.57

1.3

1.1

0.32

2.98

u/ml

0.78

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

107

2.07

2.57

1.1

1.5

5.81

6.71

u/l

0.46

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

550

1.45

2.56

1.1

2.80

4.98

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

160

2027

0.77

2.55

1.5

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.47

2.54

3.2

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

542

4806

1.17

2.54

4.6

3.0

—

(3017732) Neutrophils [#/volume] in Blood

151

1173

1.31

2.52

3.4

2.7

5.53

5.77

e9/l

0.06

113

981

(3011648) Oxygen content in Venous blood

143

1.90

2.51

3.0

3.9

11.80

11.34

0.20

143

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

421

1.51

2.50

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

302

1.60

2.48

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

144

1.89

2.46

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.39

2.46

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.39

2.46

1.6

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

203

1.74

2.45

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

189

1.76

2.41

1.9

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

491

1.46

2.40

1.9

2.5

3.00

2.92

g/l

0.32

450

(44816559) Phosphatidylethanol [Mass/volume] in Blood

443

1.48

2.37

1.2

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.65

2.36

1.3

—

(3002619) Bacteria identified in Specimen by Culture

3.04

2.35

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.26

2.34

1.9

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.83

2.34

1.4

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

169

1.79

2.33

1.3

1.2

47.64

40.60

mg/l

0.27

135

(21494755) Public health laboratory ask at order entry panel

190

2329

0.80

2.31

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

1.89

2.31

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

512

1.44

2.31

1.2

1.3

82.50

92.11

titre

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.19

2.31

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.19

2.31

1.5

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

119

1.94

2.30

1.3

1.1

0.38

1.40

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

269

1.61

2.29

1.4

—

(3021788) Differential panel - Synovial fluid

295

1.57

2.23

1.6

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

135

1.86

2.22

1.9

1.5

28.99

31.35

0.13

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.34

2.22

1.3

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

5.56

2.21

1.0

1.3

—

(3004775) Volume in Urine collected for unspecified duration

121

1.91

2.21

2.7

2.3

835.00

607.89

1.37

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

121

1.91

2.21

3.0

2.9

43.07

42.56

0.04

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.87

2.20

1.3

2.5

1.18

1.21

mmol/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

2.18

3.7

2.5

—

(3047181) Lactate [Moles/volume] in Blood

502

1.43

2.17

5.3

6.9

1.27

1.26

mmol/l

0.07

442

(3010144) Erythrocytes [#/volume] in Synovial fluid

151

1.80

2.16

1.4

13767.67

85422.15

e6/l

0.92

106

(3017354) Segmented neutrophils/100 leukocytes in Blood

144

1.82

2.15

3.5

3.0

54.16

54.20

0.00

128

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.37

2.12

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

380

1.49

2.12

5.1

4.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.14

2.08

1.1

1.3

94.56

516.72

u/l

1.73

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.99

2.05

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

139

1.81

2.05

1.8

1.4

1870.00

2007.60

e6/l

0.07

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

679

1.35

2.04

1.6

1.7

—

(3037756) Immunofixation for Serum or Plasma

294

1.54

2.03

1.3

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

425

1.45

2.03

2.9

2.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.41

2.02

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

162

1.74

2.02

1.1

317.68

262.76

mg/l

0.46

136

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.29

1.97

1.3

1.1

5.98

14.39

u/ml

—

(40767503) Oxygen content in Capillary blood by calculation

338

1.49

1.95

3.7

2.4

15.97

16.70

0.75

176

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

164

1.72

1.95

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.55

1.94

6.4

2.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.97

1.93

1.6

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

1.84

1.92

1.8

1.4

14765.75

82928.19

e6/l

0.79

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

211

1.62

1.92

2.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

251

1.56

1.90

3.3

3.4

1.50

1.40

0.07

231

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.16

1.88

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.31

1.87

3.1

1.8

—

(40757373) Influenza virus identified in Isolate

2.65

1.86

3.3

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.03

1.85

2.0

2.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.40

1.85

1.1

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

137

1.76

1.83

2.6

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

1.63

1.81

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.27

1.80

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

123

1.80

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.05

1.80

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.4

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.76

1.79

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

151

1233

1.24

1.76

1.2

102.33

146.84

iu/ml

0.80

454

(3023410) Appearance of Cerebral spinal fluid

185

1.63

1.75

2.2

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

132

1.75

1.73

1.3

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

274

2374

1.18

1.72

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

148

1.70

5.7

2.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

100

781

1.29

1.69

2.5

2.4

1009.98

4618.17

u/l

3.55

319

(3030905) Polymorphonuclear cells [#/volume] in Blood

358

1.43

1.68

3.4

3.6

4.58

4.00

e9/l

0.83

358

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.16

1.66

1.2

1.9

5.47

5.53

nmol/l

—

(3045788) Cell count panel - Pleural fluid

112

1.79

1.64

1.9

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

120

1.76

1.62

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

3.58

1.61

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

182

1.60

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

129

1.71

1.56

2.6

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.11

1.55

1.3

1.1

—

(4034850) Laboratory test

521

1.33

1.51

9.9

9.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.16

1.50

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.07

1.49

1.3

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

170

1.60

1.49

1.1

1.4

—

(3016750) Collection duration of Urine

1.81

1.47

2.1

501.30

500.04

min

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

301

1.44

1.47

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

454

1.35

1.47

1.6

1.9

4.15

5.35

iu/l

0.59

163

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

302

2672

1.15

1.47

2.0

1.8

1.42

1.44

0.18

272

2390

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

369

1.39

1.46

3.6

3.9

58.96

56.59

0.71

369

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

187

1.56

1.45

2.0

2.1

24.80

24.42

mg/l

—

(3044941) Cell count panel - Synovial fluid

261

1.46

1.43

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

413

1.37

1.43

1.1

6.31

6.33

u/ml

0.00

228

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.80

1.43

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.31

1.43

1.2

1.1

84.00

90.18

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

1.43

1.2

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.82

1.41

4.4

2.2

—

29.71

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.40

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

1.65

1.39

1.1

1.3

2.34

1.09

u/ml

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.95

1.38

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

519

4773

1.11

1.36

3.9

4.0

1.70

2.04

ug/l

1.39

473

4336

(1002224) Polysomnography panel

108

878

1.24

1.36

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

115

943

1.23

1.34

1.2

1.1

193.57

137.30

titre

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.15

1.33

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.15

1.33

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.15

1.33

1.3

—

(3000492) Spirometry study

219

1908

1.16

1.33

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

208

1.50

1.33

2.8

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.04

1.32

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

184

1.53

1.32

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

160

1.57

1.31

3.6

2.7

2.47

1.58

g/24h

0.49

(3002079) Sodium [Moles/time] in 24 hour Urine

1.81

1.31

1.1

1.4

141.07

163.66

mmol/24h

0.59

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.85

1.29

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

2.36

1.29

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.36

1.29

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.76

1.29

5.4

6.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

553

1.29

1.28

2.5

1.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.29

1.27

1.0

6.26

7.89

mg/g

—

(3012441) Differential panel - Pleural fluid

115

1.66

1.24

1.9

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.91

1.22

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

408

1.33

1.22

1.6

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

2.05

1.22

2.1

12.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

558

1.28

1.21

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.73

1.21

1.5

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.73

1.21

1.5

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.73

1.21

1.0

1.2

1557.57

1467.77

miu/ml

0.10

(3026470) Cobalt [Mass/volume] in Blood

1.75

1.19

2.2

2.0

2.15

2.71

ug/l

0.36

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

1.66

1.18

1.4

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

475

0.71

1.18

1.5

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

169

1459

1.17

4.1

4.2

5.82

20.59

ug/l

1.65

126

1186

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

141

1.57

1.17

1.5

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.78

1.17

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.78

1.17

1.2

—

(3024263) Appearance of Synovial fluid

1.78

1.17

1.6

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.16

2.4

3.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

1.16

0.0

1.5

—

(3003694) ABO and Rh group [Type] in Blood

560

5214

1.10

1.15

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.50

1.15

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.50

1.15

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

158

1.52

1.14

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

199

1.46

1.14

2.3

1.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

134

1.57

1.14

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

208

1.45

1.13

1.2

1.3

—

nmol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.90

1.12

4.1

5.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

159

1.51

1.12

1.6

1.5

1.74

1.35

promille

0.55

130

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.38

1.09

7.8

2.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.73

1.09

1.1

223.54

216.53

iu/ml

0.04

(3049717) Cytology report of Urine Cyto stain

506

1.27

1.07

1.7

2.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

270

1.38

1.06

1.1

1.0

0.49

0.38

u/ml

0.09

(3023323) Follitropin [Units/volume] in Serum or Plasma

100

832

1.21

1.06

1.4

1.5

21.84

22.91

iu/l

0.13

693

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

211

1.43

1.06

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.28

1.03

1.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

179

1.46

1.03

4.0

2.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

438

0.73

1.01

1.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.69

1.01

2.4

3.5

43.38

146.17

umol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.77

1.00

2.2

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

396

1.29

0.99

1.1

0.40

1.65

u/ml

1.68

180

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

657

1.23

0.98

1.4

1.3

216.51

228.81

miu/ml

0.10

310

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.81

0.98

1.8

2.7

—

(3014271) Vancomycin [Susceptibility]

1.81

0.98

2.4

2.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

558

1.24

0.98

3.1

3.6

7793.42

2592.85

u/ml

0.41

481

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.95

0.97

2.3

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.95

0.97

1.3

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.96

0.0

1.4

—

7.39

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.96

0.0

1.3

—

227.93

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.77

0.94

2.2

1.9

19.60

15.73

umol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.77

0.94

1.6

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

453

1.27

0.94

1.1

3.10

2.90

u/ml

0.03

235

(3022621) pH of Urine by Test strip

125

1076

1.17

0.94

4.0

2.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

158

1.46

0.93

3.5

4.4

46.73

64.26

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

374

0.72

0.93

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

1.56

0.93

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1026

0.83

0.92

1.7

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.15

0.91

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

159

1.45

0.91

5.0

3.8

—

(3008898) HLA-B27 [Presence]

701

1.21

0.90

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1011

0.83

0.89

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

130

0.54

0.87

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

111

1.54

0.87

2.2

2.7

40189.41

40884.73

ug/l

0.06

111

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

408

3797

1.09

0.86

3.6

3.5

23.35

21.22

1.19

159

1482

(3019832) Treponema pallidum Ab [Presence] in Serum

245

2224

1.11

0.86

1.9

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

388

1.27

0.85

1.6

1.7

—

(3010421) pH of Blood

451

1.25

0.85

5.0

4.1

7.43

7.41

1.31

400

(3023430) Cat dander IgE Ab [Units/volume] in Serum

292

1.31

0.83

1.1

4.60

4.98

u/ml

0.07

125

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.74

0.82

1.3

1.8

—

103.61

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

258

1.32

0.81

1.2

1.6

—

(44813793) Dust mix specific IgE antibody measurement

122

1.48

0.80

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

122

1.48

0.80

1.9

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.73

0.79

1.1

1.7

—

(3020491) Glucose [Moles/volume] in Blood

139

1.44

0.79

1.9

1.6

8.38

6.62

mmol/l

1.04

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.79

0.0

2.8

—

(3035880) pH of Pleural fluid

1.67

0.78

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.50

0.77

4.0

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.50

0.77

2.0

3.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

208

1.35

0.77

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.76

0.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

107

1.50

0.76

10.9

7.5

5879.50

242.44

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.60

0.75

2.6

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.60

0.75

2.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

295

2727

1.09

0.74

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.84

0.73

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.84

0.73

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.64

0.73

1.7

1.3

12.23

9.13

ug/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

681

1.18

0.73

1.4

1.5

9.55

7.55

u/l

0.93

558

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

0.72

2.8

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.61

0.72

3.8

2.0

—

(3006462) Nitrate [Presence] in Urine

1.62

0.71

2.1

3.4

—

(3036180) Methadone [Presence] in Urine

134

1.42

0.71

3.4

3.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

151

1.39

0.71

1.9

2.1

72.10

73.25

0.11

146

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.93

0.70

2.8

1.9

148.60

98.32

ng/l

—

(37021550) Renin [Units/volume] in Plasma --upright

1.71

0.70

1.6

1.2

47.40

65.56

mu/l

—

(3006653) Thiamine [Moles/volume] in Blood

1.51

0.69

1.1

1.3

141.86

141.99

nmol/l

0.00

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.51

0.69

4.4

3.0

643.00

983.74

u/ml

0.94

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.85

0.68

1.2

2.1

7.64

7.68

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.67

0.68

31.0

6.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

393

1.23

0.67

1.1

2.59

1.98

u/ml

0.16

206

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.79

0.66

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

128

0.62

0.64

1.3

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

112

1.43

0.63

1.3

1.2

—

57.00

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

315

1.24

0.62

1.1

1.0

3.02

4.13

u/ml

0.37

153

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.67

0.61

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

130

1.39

0.61

1.2

1.1

424.77

402.41

nmol/l

0.14

120

(3024891) Influenza virus A+B Ag [Presence] in Specimen

537

1.18

0.60

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.59

1.8

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.48

0.57

1.0

1.1

75.58

25.21

u/l

0.42

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

115

1.39

0.56

1.6

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.58

0.54

36.0

6.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.49

0.53

2.1

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

134

1.35

0.53

1.7

—

(3017704) Immunofixation for Urine

1.45

0.51

1.2

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.45

0.51

1.0

653.14

747.33

ng/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

278

2614

1.07

0.50

2.3

2.1

—

(3044927) Protein electrophoresis panel - Urine

153

1.31

0.50

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

297

2800

1.07

0.50

2.7

2.6

0.61

0.71

ug/l

1.60

174

1585

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.49

0.47

6.3

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.49

0.47

6.3

2.8

—

(3044007) Cell count panel - Peritoneal fluid

1.46

0.46

5.1

2.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.40

0.45

1.0

1.4

66.86

81.58

nmol/24h

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

294

1.19

0.43

1.4

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.66

0.42

1.2

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.66

0.42

1.3

2.4

106.00

143.70

nmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.56

0.42

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.38

0.41

3.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.38

0.41

3.3

1.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.52

0.41

1.6

1.2

0.12

1.38

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.36

0.41

3.3

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

186

1.24

0.40

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

150

1.27

0.40

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.43

0.39

1.0

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

302

2877

1.06

0.39

2.4

2.2

—

(3027315) Oxygen [Partial pressure] in Blood

372

1.16

0.39

4.3

4.2

8.59

8.70

kpa

0.17

366

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

160

1.25

0.38

1.8

1.5

11.55

12.29

umol/l

0.27

150

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.33

0.37

1.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

107

1.31

0.37

1.1

1.2

1.08

1.05

ratio

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.31

0.37

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.35

0.37

1.0

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

135

1.26

0.35

1.0

1.1

1.03

1.06

u/l

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.40

0.35

1.0

1.1

43.17

29.04

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.37

0.34

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

200

0.80

0.34

1.2

1.4

211.67

214.36

pmol/l

0.02

200

(1001926) Buprenorphine [Presence] in Urine by Screen method

892

1.09

0.34

1.8

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

246

1.18

0.34

1.1

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.31

0.33

1.3

1.2

29.33

54.63

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

174

1641

1.07

0.33

2.5

2.3

12.25

13.62

nmol/l

1.39

156

1514

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.70

0.33

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

128

1.25

0.32

2.3

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

590

0.90

0.31

1.4

1.5

—

(3033799) Differential panel - Peritoneal fluid

1.32

0.30

1.0

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

324

1.14

0.30

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

473

0.89

0.30

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.31

0.30

1.5

1.3

16.00

13.31

u/l

0.32

(3012501) Base excess in Blood by calculation

372

1.13

0.30

4.1

4.2

2.01

2.52

mmol/l

1.15

239

(3013290) Carbon dioxide [Partial pressure] in Blood

373

1.13

0.29

4.1

4.2

4.97

5.04

kpa

0.29

367

(3039443) Prostate specific Ag panel - Serum or Plasma

406

0.88

0.27

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.23

0.27

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.19

0.26

1.4

1.2

—

(3004451) EKG impression Narrative

1.23

0.25

1.9

1.2

—

(3015183) Erythrocyte sedimentation rate

114

1.23

0.25

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

161

1.18

0.24

1.9

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

816

0.93

0.23

1.9

1.8

—

(40768800) Prostate Pathology biopsy report

243

0.86

0.23

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

1.20

0.22

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.22

0.22

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.19

0.21

1.8

1.1

3.92

7.58

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.19

0.21

1.6

3.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.56

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.0

—

8.09

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

3.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

3.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

5.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.02

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.20

0.0

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

37.50

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.20

0.0

5.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

11.09

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

136

1.18

0.20

1.0

1.1

4.26

12.06

iu/ml

—

(3020650) Glucose [Presence] in Urine

1.23

0.20

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

146

1.17

0.19

1.3

1.6

—

(40761536) Microorganisms panel - Urine sediment

143

1492

0.96

0.19

5.6

3.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

395

1.09

0.19

1.1

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

137

1.17

0.18

16.3

11.2

0.59

0.62

mmol/l

0.25

126

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

1.17

0.18

1.5

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

174

0.86

0.17

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

311

1.09

0.16

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

342

1.08

0.15

4.2

3.2

19.86

24.71

mg/l

0.33

213

(3025130) Human papilloma virus identified in Specimen

217

1.11

0.14

1.6

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

314

1.08

0.14

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

170

0.88

0.13

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

100

0.80

0.13

1.8

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

1.09

0.13

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

151

1.13

0.13

14.1

786.59

820.65

nmol/l

0.12

146

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.17

0.13

1.7

1.3

24.35

34.09

nmol/l

0.78

(3028707) Methadone [Presence] in Urine by Screen method

501

1.06

0.13

2.3

3.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

0.86

0.12

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

168

0.89

0.11

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

308

1.07

0.11

1.2

1.1

6.71

2.78

u/ml

0.36

146

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

681

1.04

0.11

1.6

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

205

2006

1.02

0.10

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

535

0.95

0.10

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.14

0.10

1.0

1.1

—

(40768793) Breast Pathology biopsy report

371

0.94

0.09

1.3

—

(40765096) Chromosome analysis panel by Banding

1.06

0.09

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

763

1.04

0.09

2.5

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

655

1.04

0.09

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

380

0.95

0.09

1.1

—

(3005570) Glucose [Moles/volume] in Urine

165

1.09

0.08

1.5

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.84

0.07

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

550

0.96

0.07

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

255

1.06

0.07

1.4

1.3

6.81

7.32

mmol/l

0.55

226

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.88

0.06

1.1

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.88

0.06

1.1

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

0.91

0.06

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

537

0.97

0.06

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

141

0.92

0.05

1.6

1.4

119.54

78.53

umol/l

0.51

141

(3000012) Reticulocyte production index

198

1.06

0.05

1.5

2.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

536

0.97

0.05

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

782

1.02

0.05

2.3

1.7

2.60

4.63

mg/l

1.46

559

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

534

0.97

0.04

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

443

0.97

0.04

1.5

—

(3027944) Amphetamines [Presence] in Urine

114

1123

1.02

0.04

1.7

2.2

—

(3027008) Opiates [Presence] in Urine

116

1143

1.02

0.04

1.8

2.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

131

1.07

0.03

1.5

—

(3016879) Cocaine [Presence] in Urine

105

1065

0.99

0.03

1.7

2.3

—

(3028300) Cannabinoids [Presence] in Urine

116

1145

1.01

0.03

1.8

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.09

0.03

1.5

—

(3045142) Bone marrow Pathology biopsy report

189

0.95

0.03

1.1

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

380

0.97

0.03

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

117

0.94

0.01

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

1221

1.01

0.01

2.1

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

114

1132

1.01

0.01

1.8

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

124

1.05

0.00

1.0

—

(40768795) Lymph node Pathology biopsy report

161

0.99

0.00

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

116

1.03

0.00

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

116

1.03

0.00

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

124

0.97

0.00

1.4

1.38

1.54

g/l

1.90

124

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

296

1.01

0.00

1.4

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

198

1.01

0.00

1.5

2.2

31.95

32.54

0.28

198

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

278

1.01

0.00

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

433

0.99

0.00

1.5

1.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

212.58

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

155

1550

1.00

-0.00

2.3

2.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

10.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

140

1.00

-0.00

1.0

1.3

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.92

-0.00

1.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.89

-0.00

1.0

1.1

83.71

95.75

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

430

1.00

-0.00

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.00

-0.00

2.7

1.6

—

1357312.50

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.99

-0.00

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_NAIL_INGROW and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_NAIL_INGROW	1.527 [1.36, 1.72]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.303

During the follow-up period (1.1.1998 — 31.12.2019), 809 out of 5436 females with L12_NAIL_INGROW died.

Males

Parameter	HR [95% CI]	p-value
L12_NAIL_INGROW	1.455 [1.26, 1.68]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 676 out of 6439 males with L12_NAIL_INGROW died.

Mortality risk

Mortality risk for people of age

years, who have L12_NAIL_INGROW.

N-year risk	Females	Males
1	0.161%	0.288%
5	0.906%	1.737%
10	2.069%	4.731%
15	4.191%	8.483%
20	7.372%	14.601%

Relationships between endpoints

↥

Index endpoint: L12_NAIL_INGROW – Ingrowing nail

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Ingrowing nail

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints